Imigran (Sumatriptan Succinate)

Sumatriptan works by selectively stimulating serotonin 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve fibers. This causes vasoconstriction of dilated intracranial vessels and blocks the release of inflammatory neuropeptides, interrupting the migraine pain pathway.

The dose of Imigran is determined by the prescribing healthcare professional based on the patient’s condition, age, and response. The prescriber will decide the appropriate tablet strength, timing, and any repeat dosing if needed.

Safety data for sumatriptan in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Imigran, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Imigran (sumatriptan) belongs to the Triptan class, which specifically targets serotonin receptors to abort migraine attacks. Compared with non‑specific analgesics, Triptans provide faster and more complete relief for moderate to severe migraines, but they are contraindicated in certain cardiovascular conditions where simple analgesics may be safer.

Imigran tablets should be stored at room temperature, below 25 °C, in their original blister pack. Keep them away from excess moisture and direct sunlight to maintain stability and potency throughout the shelf life.

Imigran is taken orally as a tablet. The tablet is swallowed whole with water at the first sign of a migraine. If needed, a second dose may be taken after at least two hours, but only under the guidance of a prescriber.

Serious risks include coronary vasospasm, myocardial infarction, severe hypertension, and serotonin syndrome, especially when combined with other serotonergic drugs. Patients should seek immediate medical attention if they experience chest pain, severe headache, or any signs of an allergic reaction.

Imigran is contraindicated in patients with known hypersensitivity to sumatriptan, uncontrolled hypertension, recent myocardial infarction or stroke, peripheral vascular disease, and those taking MAO inhibitors within the past two weeks. It should also be avoided in patients with certain cardiac arrhythmias or severe hepatic impairment.